Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Motor Activity 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2Vomiting 1Pathologic Processes 1Neoplasms 1Nausea 1Malnutrition 1Lymphatic Metastasis 1Lung Neoplasms 1Liver Diseases 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Frailty 1Carcinoma, Hepatocellular 1Breast Cancer Female 1

Interventions

Cyclophosphamide 45fludarabine 32Methotrexate 24blinatumomab 20Vincristine 19Dexamethasone 19fludarabine phosphate 18Specimen Handling 17Cytarabine 17Whole-Body Irradiation 14Melphalan 13Tacrolimus 12Calcium Dobesilate 12Biopsy 12Mercaptopurine 11Busulfan 11merphos 10Peripheral Blood Stem Cell Transplantation 10Mycophenolic Acid 10Thiotepa 9Stem Cell Transplantation 9Rituximab 9Granulocyte Colony-Stimulating Factor 9Doxorubicin 9venetoclax 8ponatinib 8dexamethasone acetate 8dexamethasone 21-phosphate 8Prednisone 8Mesna 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Control Groups × 90 days × Clear all
NCT07562568 2026-05-01

SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

The First Affiliated Hospital of Soochow University

Phase 2 Not yet recruiting
160 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06816134 2026-04-23

Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting
48 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡